David Roman
Stock Analyst at Goldman Sachs
(0.74)
# 3,797
Out of 4,377 analysts
235
Total ratings
45.6%
Success rate
-2.8%
Average return
Main Sectors:
Stocks Rated by David Roman
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| MDT Medtronic | Maintained: Hold | $84 → $83 | $81.67 | +1.63% | 12 | Jun 4, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $14 → $24 | $14.23 | +68.66% | 2 | Jun 3, 2026 | |
| MOBI Mobia Medical | Initiated Coverage: Buy | $31 | $12.62 | +145.64% | 1 | Jun 1, 2026 | |
| ABT Abbott Laboratories | Maintained: Buy | $121 → $113 | $91.07 | +24.08% | 13 | May 31, 2026 | |
| HQY HealthEquity | Maintained: Sell | $89 → $88 | $88.67 | -0.76% | 5 | May 29, 2026 | |
| BSX Boston Scientific | Rated: Buy | $84 → $71 | $48.55 | +46.24% | 10 | May 27, 2026 | |
| COO The Cooper Companies | Maintained: Sell | $73 → $61 | $67.34 | -9.41% | 5 | May 27, 2026 | |
| PODD Insulet | Maintained: Buy | $237 → $205 | $153.22 | +33.79% | 6 | May 27, 2026 | |
| ISRG Intuitive Surgical | Maintained: Buy | $609 → $558 | $422.06 | +32.21% | 20 | May 27, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $25 → $21 | $19.34 | +8.58% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 → $8 | $7.05 | +13.48% | 8 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $13.89 | +22.39% | 6 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $153 | $125.00 | +22.40% | 4 | May 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 | $72.86 | +9.80% | 5 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $28 → $24 | $20.59 | +16.56% | 8 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $14.28 | +40.06% | 4 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $26 | $17.93 | +45.01% | 6 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $73 → $72 | $72.36 | -0.50% | 8 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $54 → $50 | $33.61 | +48.77% | 3 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $54 → $66 | $81.01 | -18.53% | 2 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $17 → $16 | $11.07 | +44.53% | 8 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 | $19.38 | -12.28% | 19 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $357 → $361 | $305.66 | +18.11% | 11 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $147 | $108.09 | +36.00% | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $64.67 | - | 7 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $192 → $167 | $151.16 | +10.48% | 5 | Apr 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $24 → $17 | $19.41 | -12.39% | 7 | Apr 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $19 | $15.46 | +22.90% | 3 | Mar 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $104 → $95 | $85.96 | +10.52% | 17 | Feb 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $93 → $88 | $87.33 | +0.77% | 8 | Feb 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Hold | $39 → $29 | $71.28 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $18 → $21 | $80.00 | n/a | 3 | May 16, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $103 | $99.04 | n/a | 1 | Nov 15, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $44 → $15 | $7.35 | n/a | 2 | Aug 30, 2012 |
Medtronic
Jun 4, 2026
Maintained: Hold
Price Target: $84 → $83
Current: $81.67
Upside: +1.63%
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $14 → $24
Current: $14.23
Upside: +68.66%
Mobia Medical
Jun 1, 2026
Initiated Coverage: Buy
Price Target: $31
Current: $12.62
Upside: +145.64%
Abbott Laboratories
May 31, 2026
Maintained: Buy
Price Target: $121 → $113
Current: $91.07
Upside: +24.08%
HealthEquity
May 29, 2026
Maintained: Sell
Price Target: $89 → $88
Current: $88.67
Upside: -0.76%
Boston Scientific
May 27, 2026
Rated: Buy
Price Target: $84 → $71
Current: $48.55
Upside: +46.24%
The Cooper Companies
May 27, 2026
Maintained: Sell
Price Target: $73 → $61
Current: $67.34
Upside: -9.41%
Insulet
May 27, 2026
Maintained: Buy
Price Target: $237 → $205
Current: $153.22
Upside: +33.79%
Intuitive Surgical
May 27, 2026
Maintained: Buy
Price Target: $609 → $558
Current: $422.06
Upside: +32.21%
Tandem Diabetes Care
May 27, 2026
Maintained: Hold
Price Target: $25 → $21
Current: $19.34
Upside: +8.58%
May 27, 2026
Maintained: Buy
Price Target: $7 → $8
Current: $7.05
Upside: +13.48%
May 27, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $13.89
Upside: +22.39%
May 25, 2026
Reiterated: Buy
Price Target: $153
Current: $125.00
Upside: +22.40%
May 15, 2026
Maintained: Buy
Price Target: $80
Current: $72.86
Upside: +9.80%
May 15, 2026
Rated: Hold
Price Target: $28 → $24
Current: $20.59
Upside: +16.56%
May 13, 2026
Maintained: Buy
Price Target: $20
Current: $14.28
Upside: +40.06%
May 7, 2026
Maintained: Buy
Price Target: $23 → $26
Current: $17.93
Upside: +45.01%
May 6, 2026
Maintained: Hold
Price Target: $73 → $72
Current: $72.36
Upside: -0.50%
May 6, 2026
Maintained: Buy
Price Target: $54 → $50
Current: $33.61
Upside: +48.77%
May 5, 2026
Maintained: Sell
Price Target: $54 → $66
Current: $81.01
Upside: -18.53%
May 5, 2026
Maintained: Buy
Price Target: $17 → $16
Current: $11.07
Upside: +44.53%
May 1, 2026
Maintained: Hold
Price Target: $17
Current: $19.38
Upside: -12.28%
May 1, 2026
Maintained: Hold
Price Target: $357 → $361
Current: $305.66
Upside: +18.11%
Apr 30, 2026
Maintained: Hold
Price Target: $147
Current: $108.09
Upside: +36.00%
Apr 30, 2026
Downgraded: Hold
Price Target: n/a
Current: $64.67
Upside: -
Apr 10, 2026
Initiated Coverage: Hold
Price Target: $192 → $167
Current: $151.16
Upside: +10.48%
Apr 9, 2026
Rated: Hold
Price Target: $24 → $17
Current: $19.41
Upside: -12.39%
Mar 23, 2026
Maintained: Hold
Price Target: $19
Current: $15.46
Upside: +22.90%
Feb 11, 2026
Maintained: Buy
Price Target: $104 → $95
Current: $85.96
Upside: +10.52%
Feb 10, 2026
Maintained: Sell
Price Target: $93 → $88
Current: $87.33
Upside: +0.77%
May 16, 2016
Upgraded: Hold
Price Target: $39 → $29
Current: $71.28
Upside: n/a
May 16, 2016
Downgraded: Sell
Price Target: $18 → $21
Current: $80.00
Upside: n/a
Nov 15, 2013
Maintained: Sell
Price Target: $103
Current: $99.04
Upside: n/a
Aug 30, 2012
Maintained: Hold
Price Target: $44 → $15
Current: $7.35
Upside: n/a